Home › Clostridium Infections
Clostridium Infections clinical trials recruiting in the U.S.
10 studies for Clostridium Infections are recruiting participants at sites across the United States.
Cities with the most studies
- Atlanta, GA4 studies
- New Orleans, LA3 studies
- Madison, WI3 studies
- New Haven, CT3 studies
- Boston, MA3 studies
- Warren, MI3 studies
- Cicero, IL3 studies
- Detroit, MI3 studies
- Rochester, MN3 studies
- Ann Arbor, MI3 studies
By state
- California4 studies
- Connecticut3 studies
- Florida3 studies
- Georgia4 studies
- Illinois3 studies
- Louisiana3 studies
- Massachusetts4 studies
- Michigan5 studies
- Minnesota4 studies
- New Jersey4 studies
- New York3 studies
- Virginia3 studies
- Wisconsin4 studies
Recently updated studies
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 29, 2026 · NCT06237452Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT07285213Intestinal Microbiota Transplantation in Patients Undergoing Colon Resection
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Sep 3, 2026 · NCT06370884Lifestyle and Recurrent Clostridioides Difficile Infection (CDI)
Recruiting
Ages 18 and older · All sexes · Updated Jul 8, 2026 · NCT07613645C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 15, 2026 · NCT07250724Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile
Recruiting
Ages 16 and older · All sexes · Updated Feb 20, 2026 · NCT03562741Fecal Microbiota Transplant National Registry
RecruitingObservational study
All ages · All sexes · Updated Jan 21, 2026 · NCT03325855Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection in Critically Ill Patients
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Nov 10, 2025 · NCT07221370Fecal Microbiota Transplantation for C Diff Infection
Recruiting
Ages 18 and older · All sexes · Updated Apr 13, 2025 · NCT01905709Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)
RecruitingPhase 2
Ages 18 to 105 · All sexes · Updated Oct 26, 2024 · NCT04305769From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.